Invicta Diagnostic Ltd IPO

Expanding presence in Mumbai Metropolitan Region (MMR) specifically in radiology sector.

Diagnostics provider that offers one-stop solution at affordable price.

Technical capability and technology with IT infrastructure.

Dedicated management team with significant industry experience.

Implementation of Hub and Spoke Model.

Its business and prospects may be adversely affected if the company is unable to maintain and grow its brand name and brand image.

Any interruptions at its flagship centre and other diagnostic centres may affect the company ability to process diagnostic tests, which in turn may adversely affect its business, results of operations and financial condition.

Concentrated emphasis on radiology services also exposes it to substantial risks that could adversely impact its operations, financial performance, and long-term growth prospects.

The company operations are concentrated in Mumbai Metropolitan Region (MMR), and any loss of business in such region could have an adverse effect on its business, results of operations and financial condition.

Its ability to remain competitive may be adversely affected by technological advancements, innovations in diagnostic testing and its ability to access such technology.

The company operates in a highly competitive business environment, and its inability to compete effectively could have an adverse effect on the company business, results of operations and financial condition.

Failures to establish and comply with appropriate quality standards when performing imaging, testing and diagnostics services could result in litigation and liability for it and could materially and adversely affect its reputation and results of operations.

Its may be unable to successfully implement or manage the company growth strategy.

The Restated Financial Information provided in this Red Herring Prospectus have been provided by the Peer ReviewedChartered Accountants who are not the Statutory Auditors of the Company.

The industry in which the company operates possess various risks and challenges as provided in the Industry Report titled IndustryReport on Diagnostic Industry in India dated July 22, 2024, which is exclusively prepared for the purposes of the Offerand issued by D&B and is commissioned and paid for by the Company (D&B Report).